Photo Galleries

(Image: Getty/Jacoblund)

Hired and Retired: A wave of retirements

By Ben Hargreaves

Organizations or individuals desiring change is often the reason for retirements, but the timing is often crucial and so it proved for two major institutions in the UK.

(Image: Getty/Claudiodivizia)

Hired and Retired: Leaving the room

By Ben Hargreaves

The industry has seen some high profile exits this month, with several individuals vacating, or being asked to vacate, positions on the C-suite.

(Image: Getty/Metamorworks)

Hired and Retired: In with the new

By Ben Hargreaves

A number of companies spent the early part of the year creating and then filling new positions, which has seen another big pharma company follow the trend of appointing a chief digital officer.

Pharma appointments create controversy

Hired and Retired: Controversies at the top

By Ben Hargreaves

The new year has led to a new look to executive boards across the pharma industry, but the movement has arrived with a degree of intrigue in some cases.

(Image: Getty/marchmeena29)

Hired and Retired: Summer Edition

By Ben Hargreaves

in-PharmaTechnologist gives you an overview of some of the notable hires that have taken place in the last month.

iStock/bee32

Hired while you were on holiday: pharma appointments

By Flora Southey

Novartis announces a new CEO, the MHRA re-appoints its chair, Paul Smith to lead BioAscent Discovery, and MedPharm welcomes Simon Redgrove and Jeremy Drummond.In-PharmaTechnologist catches you up on recent pharma hires.

iStock/BartekSzewczyk

Pharma executives make a move: recent appointments

By Flora Southey

Ocugen welcomes ex-Pfizer Daniel Jorgensen, the IGBMA’s Biosimilars Committee gets a new chair and drug development consultants Boyds hires two associate directors in one go.